Bill Chang
Direktor/Vorstandsmitglied bei YOURGENE HEALTH
Profil
Bill Chang is the founder of Sofiva Genomics Co., Ltd.
(founded in 2012) and Yourgene Bioscience Co, Ltd.
(founded in 2010).
At Yourgene Bioscience Co, Ltd., he held the title of Chief Executive Officer.
Currently, Dr. Chang is the Director & Chief Entrepreneur at Yourgene Health Plc, starting in 2017.
He obtained a doctorate degree from the University of Melbourne.
Aktive Positionen von Bill Chang
| Unternehmen | Position | Beginn |
|---|---|---|
| YOURGENE HEALTH | Direktor/Vorstandsmitglied | 27.02.2017 |
Ehemalige bekannte Positionen von Bill Chang
| Unternehmen | Position | Ende |
|---|---|---|
| SOFIVA GENOMICS CO.,LTD. | Gründer | - |
Yourgene Bioscience Co, Ltd.
 Yourgene Bioscience Co, Ltd. Miscellaneous Commercial ServicesCommercial Services Yourgene Bioscience Co., Ltd. provides bioinformatics solutions, Cloud-based NGS Platform and genetic testing services. The company was founded by Bill Chang in 2010 and is headquartered in New Taipei City, Taiwan. | Vorstandsvorsitzender | - |
Ausbildung von Bill Chang
| University of Melbourne | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SOFIVA GENOMICS CO.,LTD. | Health Services |
| Private Unternehmen | 2 |
|---|---|
Yourgene Bioscience Co, Ltd.
Yourgene Bioscience Co, Ltd. Miscellaneous Commercial ServicesCommercial Services Yourgene Bioscience Co., Ltd. provides bioinformatics solutions, Cloud-based NGS Platform and genetic testing services. The company was founded by Bill Chang in 2010 and is headquartered in New Taipei City, Taiwan. | Commercial Services |
Yourgene Health Plc
 Yourgene Health Plc Medical SpecialtiesHealth Technology Yourgene Health Plc engages in the development and commercialization of genomic services and technologies. It primarily manufactures molecular diagnostic solutions for reproductive health, precision medicine and infectious diseases. It operates through the Genomic Technologies and Genomic Services segments. The Genomic Technologies segment represents the in vitro diagnostic products, software and instrumentation manufactured by the group. The Genomic Services segment operates testing laboratories in Taiwan and the UK, and provides services to clinicians, third party clinical service providers and contract research organizations. The company was founded on April 13, 2000 and is headquartered in Manchester, the United Kingdom. | Health Technology |
